April 2020 - Congrats to Leila, Maximilian and Mina for publishing their review manuscripts in the themed issue "EV bioengineering" in Advanced Drug Delivery Reviews - well done!
Gregor has been selected as one of the 2020 ERC Starting Grant Awardees!
BIOGENIC NANOTHERAPEUTICS
We are the Junior Research Group Biogenic Nanotherapeutics (BION) at the Helmholtz Institute for Pharmaceutical Research Saarland and the Chair for Pharmaceutical Biology at Friedrich-Alexander University Erlangen.
Our aim is to engineer smart biomimetic drug carriers utilising principles established in nature. We are dedicated to using cutting-edge methodologies in nanoparticle formulation and imaging combined with tangible pharmaceutical know-how in the field of targeted drug delivery.
German Society for Extracellular Vesicles GSEV - the national network for scientists and professionals working in the field of exosomes, microvesicles and other cell-derived vesicles - more information
NEWS - Our lab featured on TV and in print - more here
FUHRMANN | LAB
Chair for Pharmaceutical Biology
Friedrich-Alexander University Erlangen
Department Biology
Staudtstr. 5
91058
Helmholtz-Centre for Infection Research
Helmholtz-Institute for Pharmaceutical Sciences Saarland (HIPS)
Saarland University Campus E8.1
66123 Saarbrücken
Germany
Our research is supported by the European Research Council and the NanoMatFutur programme from the Federal Ministry of Education and Research (BMBF). Project BEVA
Other funding schemes:
- Volkswagen Foundation
- DAAD
- Studienstiftung
- Marie-Curie Actions
- Phospholipid Research Center
- Saarland University
Druckversion 